HCPLive

Infectious Disease
The MD Magazine Infectious Disease specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Latest Headlines

David Nash: Developing a College of Population Health
The field of population health may still be a relatively new venture but work is being done on a variety of levels to raise its profile and make it a larger contributor to the medical community as a whole.
For many veteran doctors there may be a leaning toward staying the course that has guided them through their careers. As times change there have been signs that doctors must also adapt to the changing medical landscape.
There may not be a lot known about population medicine across the medical community but those involved believe as more is known about the specialty the more benefit it can provide for doctors and patients alike.
At the American College of Cardiology's annual meeting in Chicago the opening discussion in front of thousands of the top doctors across the country focused on a developing specialty aimed at improving patient health in non-traditional ways.
People with genotype 1 hepatitis C, who make up about 74% of the hepatitis C population in the United States, will soon have a new treatment option available to them.
Studies have shown that adults born between 1945 and 1965 (aka “baby boomers”) are more likely to have come into contact with hepatitis C.
Formerly known as alternative or complimentary medicine, integrative medicine is a new venture in the field aiming to bring together the best of traditional care and other approaches to help patients in a variety of specialties.
It was back in April that researchers from Georgetown University reported the first case of Alzheimer’s disease in a person living with the human immunodeficiency virus (HIV). Now the case report will be presented at the Alzheimer’s Association International Conference (AAIC) 2016 in Toronto, Canada on July 27.
Recent advances in the field of hepatitis C therapy has prompted the European Medicines Agency to update its guideline for designing clinical trials on investigational direct-acting antiviral drugs that target chronic infection of the virus.

Most Popular in Infectious Disease

Recent Published Journal

@MDMagazine

$vacMongoViewPlus$ $vAR$